A Phase 2b Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
Supported projects > Other Supported Projects · 2017
Authors: Elif Erol, NİLGÜN KÜLTÜRSAY, Mehmet YALAZ, Nalan Baltacı, Özge ALTUN, Demet TEREK
2017-2019, Other Supported Projects, R & D Project, Completed